Vélfag's Struggles Intensify as Layoffs Hit the Company
Alfred Tulinius, the chairman of the board at Vélfag, has confirmed that the company made the difficult...
In a significant development, a bill currently under review on the government's consultation portal proposes to eliminate a longstanding provision that permits mergers in...
Novo Nordisk has made the pivotal decision to halt the development of its Alzheimer's drug that utilizes semaglutide. This announcement follows the release of...
Þorsteinn Már Baldvinsson Honored with Þjðmál 2025 Award
In a splendid ceremony at the Whale Museum, Þorsteinn Már Baldvinsson, the former CEO of Samherji, was...